Monday, September 04, 2006

Back to the day job.

Tomorrow I return to work, well, the day job, after taking the whole of August (and a few odd days of September) off.

What did I do?

I grew a beard. And shaved it off.

I went to St Petersburg and communed with the spirit of Dostoevsky.

I went to Norfolk and ate fish and chips and did other English seasidey stuff with the (extended) family.

I went to Edinburgh to sample the fringe.

I wasted a lot of time on the internet. I have a myspace addiction now.

Oh, and I did some writing. Not enough. But some.

So the endless summer has finally, and all too quickly, ended. This last day I spent with the kids. (They're back at school on Wednesday, or rather Claire is. The infants' school rang this morning and coolly announced the building work isn't finished so can we keep Luke at home for another day!) We baked cookies in the morning, went for a stroll around Crouch End, then Claire and Luke did some more baking in the afternoon, me banished from the kitchen because they wanted to make a treat for Rachel and me.

I got to clean up after them.

But it was a great day. They hardly watched TV at all and I don't think they fell out once. I even managed to do some reading. (Nearing the end of To The Hermitage.)

And now it's back to work, and Highgate Tube Station in the morning. I can't help thinking I should have kept the beard.


Debi said...

Work? Wossat???
I hope it doesn't tie up your spirit but rather enables you to keep on keeping on.
I suspect I wrote more when I was working - prompting fears that I might operate better under pressure. No! I don't want to be that person! Personally I blame all you guys for ensnaring me in blogdom ...
Hope your sweet days of summer turn into alluring Autumn ...

roger said...

Thanks debi.

Just one thing, though. Writing is work, no?

Debi said...

No, no. Writing is more like eating. Or breathing ...

Anonymous said...

» International Trial Of Novel Breast Cancer Drug
14/12/06 07:03 from Breast cancer blog from
A clinical trial of a new targeted breast cancer drug, led by
physicians at Massachusetts General Hospital (MGH) Cancer
Center, has begun enrolling patients. The TEACH (Tykerb
Evaluation After CHemotherapy) trial will investigate ...

For useful content on breast cancer cure, breast cancer current treatment and breast cancer detection unit: check
the url is